Pharmalot... Pharmalittle... Good Morning

Hello, folks, and how are you today? The sun is peeking through the clouds hovering over the Pharmalot corporate campus this morning, where the short people are, as usual, hustling off to the school houses, the leaves are blanketing the grounds and the official mascots are chasing down wild animals. Quite a scene. As for us, we are hustling a bit ourselves since we hope to attend an interesting panel later, which will require us to close the laptop for a spell. Nonetheless, we have the usual line up of items for you to peruse. So here you go. Have a grand day and stay in touch... Reckitt Benckiser Starts A Strategic Review Of Its Pharma Unit (Reuters) Novartis Raises Forecast As Generic Diovan Is A No-Show (Bloomberg News) UK's MHRA Pulls Approval For Second Wockhardt Plant (Business Standard) PFizer To Continue Developing Pain Therapeutics Painkiller (Reuters) FDA Tags Smurthi Organics For Plant Problems (Indian Express) PDL BioPharma Buys Diabetes Royalty Stream From Depomed (BioCentury) Roche's Avastin Boosts Survival In Advanced Ovarian Cancer (Pharma Times) ...Read more
Source: Pharmalot - Category: Pharma Commentators Authors: Source Type: blogs